Registry for evaluating care in acute coronary syndrome
Future Optimal Research and Care Evaluation: On the Way to "Personalized Medicine" With an Ongoing Registry of Patients in Daily Clinical Practice (Hart Beter/ FORCE-ACS)
St. Antonius Hospital · NCT03823547
This study is creating a registry to track how well different treatments and devices work for people with acute coronary syndrome in real-life situations.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 99999 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | St. Antonius Hospital (other) |
| Locations | 4 sites (Apeldoorn, Gelderland and 3 other locations) |
| Trial ID | NCT03823547 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a registry to evaluate the long-term clinical impact of diagnostics, treatments, and devices used for acute coronary syndrome (ACS). It addresses the limitations of randomized controlled trials (RCTs) by capturing real-world data on patient characteristics and treatment outcomes. The study will involve prospective registration of patients presenting with ACS, allowing for a comprehensive analysis of care quality and effectiveness in routine clinical practice. The use of electronic patient records will facilitate the collection of clinical parameters and outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who present with acute coronary syndrome.
Not a fit: Patients who are unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved quality of care and treatment outcomes for patients with acute coronary syndrome.
How similar studies have performed: Other observational studies have shown success in evaluating real-world treatment effectiveness, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients presenting with ACS * Age ≥ 18 years Exclusion Criteria: * No oral or signed informed consent available.
Where this trial is running
Apeldoorn, Gelderland and 3 other locations
- Gelre Ziekenhuizem — Apeldoorn, Gelderland, Netherlands (RECRUITING)
- Rijnstate Arnhem — Arnhem, Gelderland, Netherlands (RECRUITING)
- Gelderse Vallei — Ede, Gelderland, Netherlands (RECRUITING)
- Ziekenhuis Rivierenland — Tiel, Gelderland, Netherlands (RECRUITING)
Study contacts
- Study coordinator: Dean R.P.P. Chan Pin Yin, MD
- Email: d.chanpinyin@antoniusziekenhuis.nl
- Phone: 088 - 320 12 28
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Acute Coronary Syndrome, Myocardial Infarction, DAPT, Dual Antiplatelet Therapy, Myocardial infarction, Ticagrelor, Prasugrel, Clopidogrel